Evidence map›Paper›PMID 35485770›Full record

ArticleHuman mutation2022

Partial loss-of-function variant in neuregulin 1 identified in family with heritable peripheral neuropathy.

Daniel E Lysko, Ana M Meireles, Chiara Folland, Elyshia McNamara, Nigel G Laing, Phillipa J Lamont, Gianina Ravenscroft, William S Talbot

Open access · greenAbstract readCase Reports
In one paragraph

Article in Human mutation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Modeling of Charcot-Marie-Tooth disease in zebrafish.Frontiers in molecular neuroscience · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Daniel E LyskoDepartment of Developmental Biology, Stanford University, Stanford, California, USA.ORCID 0000-0001-7076-045X
Ana M MeirelesDepartment of Developmental Biology, Stanford University, Stanford, California, USA.
Chiara FollandHarry Perkins Institute of Medical Research, Nedlands, Western Australia, Australia.
Elyshia McNamaraHarry Perkins Institute of Medical Research, Nedlands, Western Australia, Australia.
Nigel G LaingHarry Perkins Institute of Medical Research, Nedlands, Western Australia, Australia.
Phillipa J LamontDepartment of Neurology, Neurology, Royal Perth Hospital, Perth, Western Australia, Australia.
Gianina RavenscroftHarry Perkins Institute of Medical Research, Nedlands, Western Australia, Australia.
William S TalbotDepartment of Developmental Biology, Stanford University, Stanford, California, USA.ORCID 0000-0002-2048-7472
The University of Western Australia · AUStanford University · USRoyal Perth Hospital · AU

Funding

Genetic and cellular analysis of glial development and function in vertebratesR35NS111584 · NINDS · STANFORD UNIVERSITY · PI WILLIAM S TALBOT · 2019 to 2026
$4.3M
The role of Nrg1 signaling in Schwann cell development and myelinationF32NS095466 · NINDS · STANFORD UNIVERSITY · PI LYSKO, DANIEL · 2015 to 2018
$176k
NINDS NIH HHS F32 NS095466NINDS NIH HHS R35 NS111584
6 · The paper itself

Abstract

Neuregulin 1 signals are essential for the development and function of Schwann cells, which form the myelin sheath on peripheral axons. Disruption of myelin in the peripheral nervous system can lead to peripheral neuropathy, which is characterized by reduced axonal conduction velocity and sensorimotor deficits. Charcot-Marie-Tooth disease is a group of heritable peripheral neuropathies that may be caused by variants in nearly 100 genes. Despite the evidence that Neuregulin 1 is essential for many aspects of Schwann cell development, previous studies have not reported variants in the neuregulin 1 gene (NRG1) in patients with peripheral neuropathy. We have identified a rare missense variant in NRG1 that is homozygous in a patient with sensory and motor deficits consistent with mixed axonal and de-myelinating peripheral neuropathy. Our in vivo functional studies in zebrafish indicate that the patient variant partially reduces NRG1 function. This study tentatively suggests that variants at the NRG1 locus may cause peripheral neuropathy and that NRG1 should be investigated in families with peripheral neuropathy of unknown cause.

Indexed as

Charcot-Marie-Tooth DiseaseNeuregulin-1AnimalsAxonsHumansMyelin SheathSchwann CellsZebrafishNeuregulin-1NRG1 protein, humanfunctional genomicsneuregulin 1NRG1peripheral neuropathyzebrafish

Identifiers

PMID35485770
PMCPMC9357049
OpenAlexW4225124993

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.